FDA has authorized marketing of the GI Genius, the first device that uses artificial intelligence based on machine learning to assist clinicians in detecting lesions (such as polyps or suspected tumors) in the colon in real time during a colonoscopy.
The American Association for Cancer Research will honor the following cancer researchers, physician-scientists, advocates, and policymakers for their achievements during the virtual AACR annual meeting held April 10-15 and May 17-21.
Deborah Schrag was named chair of the Department of Medicine at Memorial Sloan Kettering.
Carolyn Starrett, leader of Flatiron Health’ community oncology business, was named chief executive officer of the company effective April 16.
Brian Bolwell was named to the newly created role of chair, physician leadership and development within the Mandel Global Leadership and Learning Institute at Cleveland Clinic.
The California Senate passed the Cancer Patients Bill of Rights (SCR 11) with a unanimous vote from the state Senate (The Cancer Letter, Feb. 19, 2021).
Elizabeth Herbert was named vice president of Network Services at Smilow Cancer Hospital.
Nine teams representing 19 lead and co-lead investigators across Harvard Medical School and its affiliated hospitals have received a total of over $9 million to research rare cares.
University of Kansas Cancer Center receives $4.2M from NCI to research breast cancer chemoprevention
Researchers at the University of Kansas Cancer Center have received a $4.2 million, five-year grant from NCI to study the effects of bazedoxifene and low-dose conjugated estrogen in women who are at increased risk for developing breast cancer and are experiencing menopausal symptoms.
Thomas J. Kelly Jr., was named associate director for cancer research training and education at the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences.
